The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders

Mol Neurobiol. 2016 Sep;53(7):4638-58. doi: 10.1007/s12035-015-9392-y. Epub 2015 Aug 27.

Abstract

Oxidative and nitrosative stress (O&NS) is causatively implicated in the pathogenesis of Alzheimer's and Parkinson's disease, multiple sclerosis, chronic fatigue syndrome, schizophrenia and depression. Many of the consequences stemming from O&NS, including damage to proteins, lipids and DNA, are well known, whereas the effects of O&NS on lipoprotein-based cellular signalling involving palmitoylation and plasma membrane lipid rafts are less well documented. The aim of this narrative review is to discuss the mechanisms involved in lipid-based signalling, including palmitoylation, membrane/lipid raft (MLR) and n-3 polyunsaturated fatty acid (PUFA) functions, the effects of O&NS processes on these processes and their role in the abovementioned diseases. S-palmitoylation is a post-translational modification, which regulates protein trafficking and association with the plasma membrane, protein subcellular location and functions. Palmitoylation and MRLs play a key role in neuronal functions, including glutamatergic neurotransmission, and immune-inflammatory responses. Palmitoylation, MLRs and n-3 PUFAs are vulnerable to the corruptive effects of O&NS. Chronic O&NS inhibits palmitoylation and causes profound changes in lipid membrane composition, e.g. n-3 PUFA depletion, increased membrane permeability and reduced fluidity, which together lead to disorders in intracellular signal transduction, receptor dysfunction and increased neurotoxicity. Disruption of lipid-based signalling is a source of the neuroimmune disorders involved in the pathophysiology of the abovementioned diseases. n-3 PUFA supplementation is a rational therapeutic approach targeting disruptions in lipid-based signalling.

Keywords: Chronic fatigue; Cytokines; Depression; Inflammation; Metabolism; Oxidative and nitrosative stress.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Membrane / drug effects
  • Cell Membrane / immunology
  • Cell Membrane / metabolism
  • Drug Delivery Systems* / trends
  • Fatty Acids, Omega-3 / administration & dosage
  • Humans
  • Lipoylation / drug effects
  • Lipoylation / physiology*
  • Membrane Microdomains / drug effects
  • Membrane Microdomains / immunology
  • Membrane Microdomains / metabolism*
  • Nervous System Diseases / drug therapy
  • Nervous System Diseases / immunology
  • Nervous System Diseases / metabolism*
  • Neuroimmunomodulation / drug effects
  • Neuroimmunomodulation / physiology
  • Nitrosative Stress / drug effects
  • Nitrosative Stress / physiology*
  • Oxidation-Reduction
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Fatty Acids, Omega-3